€28.40
0.00% today
Xetra, Jun 12, 11:41 am CET
ISIN
DE000A2P4LJ5
Symbol
PSG
Index
Sector
Industry

Pharmasgp Holding Stock price

€28.40
+0.60 2.16% 1M
+5.00 21.37% 6M
+3.40 13.60% YTD
+5.80 25.66% 1Y
-6.10 17.68% 5Y
-6.10 17.68% 10Y
-6.10 17.68% 20Y
Xetra, Closing price Wed, Jun 11 2025
-0.40 1.39%
ISIN
DE000A2P4LJ5
Symbol
PSG
Index
Sector
Industry

Key metrics

Market capitalization €345.60m
Enterprise Value €377.75m
P/E (TTM) P/E ratio 18.09
EV/FCF (TTM) EV/FCF 13.21
EV/Sales (TTM) EV/Sales 3.31
P/S ratio (TTM) P/S ratio 3.03
P/B ratio (TTM) P/B ratio 9.22
Dividend yield 4.79%
Last dividend (FY24) €1.36
Revenue growth (TTM) Revenue growth 16.86%
Revenue (TTM) Revenue €114.00m
EBIT (operating result TTM) EBIT €26.76m
Free Cash Flow (TTM) Free Cash Flow €28.59m
Cash position €37.77m
EPS (TTM) EPS €1.57
Show more

Is Pharmasgp Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Pharmasgp Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pharmasgp Holding:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Pharmasgp Holding:

Buy
100%

Financial data from Pharmasgp Holding

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
114 114
17% 17%
100%
- Direct Costs 10 10
13% 13%
9%
104 104
17% 17%
91%
- Selling and Administrative Expenses 58 58
26% 26%
51%
- Research and Development Expense - -
-
-
36 36
14% 14%
32%
- Depreciation and Amortization 9.40 9.40
0% 0%
8%
EBIT (Operating Income) EBIT 27 27
19% 19%
23%
Net Profit 19 19
25% 25%
16%

In millions EUR.

Don't miss a Thing! We will send you all news about Pharmasgp Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

PharmaSGP Holding SE engages in the manufacture of non-chemical, over-the-counter pharmaceutical products. Its product brands include RubaXX, Restaxil, FULMINAN, DESEO, Neradin, and TAUMEA. The company is headquartered in Gräfelfing, Germany.

Head office Germany
CEO Peter Gerckens
Employees 89
Founded 2012
Website pharmasgp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today